Homeostatic Roles of Eosinophils in Asthma
NCT06676397 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-11-06
Summary
The HOMEOS study is an exploratory, observational, and monocentric research. It focuses on characterizing the homeostatic roles of eosinophils in severe asthma. The primary objective is to identify eosinophil subpopulations among different groups of severe asthmatic patients using flow cytometry. The study aims to advance understanding of eosinophil diversity, which could guide new therapeutic approaches .
Conditions
- Asthma; Eosinophilic
Interventions
- PROCEDURE
-
Blood Punction
venous blood sampling
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Besancon
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-12-04
- Primary Completion
- 2026-12-04
- Completion
- 2027-02-04
More Related Trials
-
Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients.
NCT05001529 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)
NCT00770900 ·Status: COMPLETED ·Phase: PHASE4
-
Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins
NCT05762627 ·Status: NOT_YET_RECRUITING
-
A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)
NCT06348407 ·Status: RECRUITING
-
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients
NCT04181190 ·Status: COMPLETED
-
Intense Airway Eosinophilia in Asthma
NCT03696914 ·Status: COMPLETED
-
Functional Activity of Airway Eosinophils in Allergic Disease
NCT01026532 ·Status: COMPLETED
-
The Effect of Salmeterol on Eosinophil (EOS) Function
NCT00214019 ·Status: COMPLETED ·Phase: NA
-
Changes in Gene Transcription and Immunophenotypes Following Mepolizumab Treatment for Asthma
NCT05002621 ·Status: COMPLETED
-
Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control Asthma
NCT01397760 ·Status: UNKNOWN
-
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
An Investigation of Tumor Necrosis Factor (TNF)-Alpha in Asthma Using Biopsy Explants and Primary Bronchial Epithelial Cell Cultures
NCT01161303 ·Status: COMPLETED
-
Exploring Asthma Exacerbations in Mepolizumab Treated Patients
NCT03324230 ·Status: COMPLETED
-
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
NCT06621056 ·Status: RECRUITING
-
Molecular Mechanism of Asthma
NCT00180726 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma
NCT04049175 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Genic Expression Profiles of the Epithelium of the Nose and Bronchi in Healthy and Allergic Subjects
NCT01923519 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
NCT00670930 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Mepolizumab on Decrease of Systemic Corticosteroids in Patients With Severe Eosinophilic Asthma
NCT03453021 ·Status: COMPLETED
-
Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 Targeting
NCT05689931 ·Status: UNKNOWN
-
A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
NCT01703312 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Non-Eosinophilic Biological Effects of IL-5
NCT06026202 ·Status: RECRUITING
-
Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
NCT01007149 ·Status: COMPLETED ·Phase: PHASE3
-
Inflammatory Indices in Predicting the Failure of Inhaled Corticosteroids Reduction in Young Participants With Asthma
NCT03788057 ·Status: COMPLETED ·Phase: NA
-
Functional Lung MRI for Early Treatment Response Assessment for Patients With Eosinophilic Asthma
NCT04512521 ·Status: UNKNOWN